CDEK
← All organizations

Myrexis Inc.

For profitContributed to NME

Also known as: AssureRx Health, Inc. | Myriad Genetic Laboratories, Inc. | Myriad Genetics | Myriad Genetics, Inc. | Myriad Therapeutics, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Feb 1, 2002

Last known activity

Jul 29, 2022

Defunct as of Feb 1, 2012

Timeline

1990s

  1. Jun 1, 1991

    Myrexis Inc.— Founded

2000s

  1. Apr 10, 2008

    NaturNorth Technologies— Acquired

2010s

  1. Apr 27, 2011

    Rules-Based Medicine, Inc.— Acquired

  2. Feb 1, 2012

    Myrexis Inc.— Defunct

  3. Feb 4, 2014

    Crescendo Bioscience— Acquired

  4. Feb 27, 2015

    Privatklinik Dr. Robert Schindlbeck— Acquired

  5. May 31, 2016

    Sividon Diagnostics— Acquired

  6. Aug 3, 2016

    Assurex Health— Acquired

  7. May 28, 2018

    Counsyl— Acquired

Drugs by trial phase (28 distinct, 44 trials)

Phase 4 (4 own, 0 via acquisition)

Phase 1 (3 own, 1 via acquisition)

Indications

Studied for

Subsidiaries (7 direct, 7 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Salt Lake City, UT, US Jun 1, 1991
Last known activity
Jul 29, 2022

Notes

--- Pre-folding founded info: 1999-06-01 Salt Lake City UT US https://en.wikipedia.org/wiki/Myrexis ---